ESR1 and breast cancer: We exemplify RedeR's visualization and analysis capabilities in a case study based on the re-analysis of gene expression and chromatin immunoprecipitation (ChIP)-on-chip data from an estrogen receptor (ER) study in the MCF-7 breast cancer cell line [6].